{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:23:34Z","timestamp":1785835414611,"version":"3.56.0"},"reference-count":78,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Research Institute"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Population and Systems Medicine Board","award":["MR\/T017279\/1"],"award-info":[{"award-number":["MR\/T017279\/1"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC Efficacy and Mechanism Evaluation Programme","award":["12\/10\/04"],"award-info":[{"award-number":["12\/10\/04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The liver\/foregut satiety hormone liver-expressed antimicrobial peptide 2 (LEAP2) is an inverse agonist at the acyl ghrelin receptor (GHSR), increasing after food intake and decreasing after bariatric surgery and short-term nonsurgical weight loss, but effects of long-term dietary weight loss are unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this study was to examine and compare the effects of these interventions on fasting and postprandial plasma LEAP2 and investigate potential metabolic mediators of changes in plasma LEAP2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Plasma LEAP2 was measured in a previously published 2-year trial comparing standard medical management (SMM) (including 600-kcal\/day deficit) with duodenal-jejunal bypass liner (DJBL, Endobarrier) insertion (explanted after 1 year) in adults with obesity and inadequately controlled type 2 diabetes mellitus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the SMM group (n = 25-37), weight decreased by 4.3%, 8.1%, 7.8%, and 6.4% at 2, 26, 50, and 104 weeks and fasting plasma LEAP2 decreased from baseline mean \u00b1 SD 15.3 \u00b1 0.9 ng\/mL by 1.7, 3.8, 2.1, and 2.0\u2005ng\/mL, respectively. Absolute\/decreases in fasting plasma LEAP2 positively correlated with absolute\/decreases in body mass index, glycated hemoglobin A1c, fasting plasma glucose, serum insulin, homeostatic model assessment for insulin resistance, and serum triglycerides. Despite greater weight loss in the DJBL group (n = 23-30) at 26 to 50 weeks (10.4%-11.4%), the decrease in fasting plasma LEAP2 was delayed and attenuated (vs SMM), which may contribute to greater weight loss by attenuating GHSR signaling. Plasma LEAP2 did not increase with weight regain from 50 to 104 weeks after DJBL explant, suggesting a new set point with weight loss maintenance. Increases in plasma LEAP2 after a 600-kcal meal (10.8%-16.1% at 1-2\u2005hours) were unaffected by weight loss, improved glucose metabolism, or DJBL insertion (n = 9-25), suggesting liver rather than duodenum\/jejunum may be the primary source of postprandial LEAP2 secretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings add to our understanding of the regulation and potential physiological role of plasma LEAP2.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvae214","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:32:49Z","timestamp":1733859169000},"source":"Crossref","is-referenced-by-count":10,"title":["Satiety Hormone LEAP2 After Low-Calorie Diet With\/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus"],"prefix":"10.1210","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-789X","authenticated-orcid":false,"given":"Mimoza","family":"Emini","sequence":"first","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1745-0345","authenticated-orcid":false,"given":"Raghav","family":"Bhargava","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9228-8712","authenticated-orcid":false,"given":"Madhawi","family":"Aldhwayan","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences, King Saud University , Riyadh 11451 ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navpreet","family":"Chhina","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-4067","authenticated-orcid":false,"given":"Marcela","family":"Rodriguez Flores","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-4379","authenticated-orcid":false,"given":"Ghadah","family":"Aldubaikhi","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaz","family":"Al Lababidi","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0020-4391","authenticated-orcid":false,"given":"Werd","family":"Al-Najim","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Diabetes and Reproduction, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D","family":"Miras","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Diabetes and Reproduction, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9105-4025","authenticated-orcid":false,"given":"Aruchuna","family":"Ruban","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St. Mary\u2018s Hospital, London W2 1NY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-2100","authenticated-orcid":false,"given":"Michael A","family":"Glaysher","sequence":"additional","affiliation":[{"name":"Division of Surgery, University Hospital Southampton NHS Foundation Trust , Southampton SO16 6YD ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4122-8899","authenticated-orcid":false,"given":"Christina G","family":"Prechtl","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Department of Public Health, Imperial College London , London W12 7TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-5110","authenticated-orcid":false,"given":"James P","family":"Byrne","sequence":"additional","affiliation":[{"name":"Division of Surgery, University Hospital Southampton NHS Foundation Trust , Southampton SO16 6YD ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-9139","authenticated-orcid":false,"given":"Julian P","family":"Teare","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , St. Mary\u2018s Hospital, London W2 1NY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8179-7071","authenticated-orcid":false,"given":"Anthony P","family":"Goldstone","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College London , Hammersmith Hospital, London W12 0NN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"2025021210535828500_bvae214-B1","author":"WHO"},{"issue":"10382","key":"2025021210535828500_bvae214-B2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"Lancet"},{"key":"2025021210535828500_bvae214-B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yfrne.2004.03.002","article-title":"Ghrelin\u2014a hormone with multiple functions","volume":"25","author":"Korbonits","year":"2004","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2025021210535828500_bvae214-B4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpendmet0080","article-title":"Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone","volume":"2","author":"Kojima","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"11","key":"2025021210535828500_bvae214-B5","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.peptides.2011.07.002","article-title":"Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications","volume":"32","author":"Stengel","year":"2011","journal-title":"Peptides"},{"issue":"17","key":"2025021210535828500_bvae214-B6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2025021210535828500_bvae214-B7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13679-018-0300-4","article-title":"Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon","volume":"7","author":"Srivastava","year":"2018","journal-title":"Curr Obes Rep"},{"key":"2025021210535828500_bvae214-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.11.005","article-title":"Gut-brain axis and addictive disorders: a review with focus on alcohol and drugs of abuse","volume":"196","author":"Jerlhag","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"10","key":"2025021210535828500_bvae214-B9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11892-019-1211-9","article-title":"Pharmacological modulation of ghrelin to induce weight loss: successes and challenges","volume":"19","author":"Schalla","year":"2019","journal-title":"Curr Diab Rep"},{"key":"2025021210535828500_bvae214-B10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1101\/sqb.2011.76.010447","article-title":"Surviving starvation: essential role of the ghrelin-growth hormone axis","volume":"76","author":"Goldstein","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"6","key":"2025021210535828500_bvae214-B11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol Metab"},{"key":"2025021210535828500_bvae214-B12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","article-title":"Ghrelin regulation of glucose metabolism","volume":"100","author":"Poher","year":"2018","journal-title":"Peptides"},{"issue":"8","key":"2025021210535828500_bvae214-B13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/ijo.2017.96","article-title":"Timeline of changes in appetite during weight loss with a ketogenic diet","volume":"41","author":"Nymo","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"2025021210535828500_bvae214-B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.clnu.2017.04.002","article-title":"Compensatory mechanisms activated with intermittent energy restriction: a randomized control trial","volume":"37","author":"Coutinho","year":"2018","journal-title":"Clin Nutr"},{"issue":"8","key":"2025021210535828500_bvae214-B15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41366-018-0119-9","article-title":"Investigation of the long-term sustainability of changes in appetite after weight loss","volume":"42","author":"Nymo","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2025021210535828500_bvae214-B16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/ajcn\/nqz002","article-title":"Investigating the effect of sex and ketosis on weight-loss-induced changes in appetite","volume":"109","author":"Lyngstad","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"2025021210535828500_bvae214-B17","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1172\/JCI125332","article-title":"LEAP2 changes with body mass and food intake in humans and mice","volume":"129","author":"Mani","year":"2019","journal-title":"J Clin Invest"},{"issue":"8","key":"2025021210535828500_bvae214-B18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1249\/MSS.0000000000002636","article-title":"Continuous versus intermittent dieting for fat loss and fat-free mass retention in resistance-trained adults: the ICECAP trial","volume":"53","author":"Peos","year":"2021","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2025021210535828500_bvae214-B19","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41598-022-06636-3","article-title":"Circulating acyl and des-acyl ghrelin levels in obese adults: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"2025021210535828500_bvae214-B20","doi-asserted-by":"crossref","first-page":"e13531","DOI":"10.1111\/obr.13531","article-title":"Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity-A systematic review and meta-analysis","volume":"24","author":"Aukan","year":"2023","journal-title":"Obes Rev"},{"issue":"2","key":"2025021210535828500_bvae214-B21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/en.2012-1421","article-title":"Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner","volume":"154","author":"Briggs","year":"2013","journal-title":"Endocrinology"},{"issue":"10","key":"2025021210535828500_bvae214-B22","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/oby.2006.197","article-title":"Rise of plasma ghrelin with weight loss is not sustained during weight maintenance","volume":"14","author":"Garcia","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"2025021210535828500_bvae214-B23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41430-020-0568-9","article-title":"The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study","volume":"74","author":"Thom","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"2025021210535828500_bvae214-B24","doi-asserted-by":"crossref","first-page":"640538","DOI":"10.3389\/fnut.2021.640538","article-title":"Can a higher protein\/low glycemic Index vs. a conventional diet attenuate changes in appetite and gut hormones following weight loss? A 3\u2013year PREVIEW sub-study","volume":"8","author":"Buso","year":"2021","journal-title":"Front Nutr"},{"issue":"1","key":"2025021210535828500_bvae214-B25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41523-021-00260-6","article-title":"Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors","volume":"7","author":"Puklin","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"2025021210535828500_bvae214-B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/dom.14274","article-title":"Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial (DiRECT)","volume":"23","author":"Thom","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2025021210535828500_bvae214-B27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1110\/ps.0213603","article-title":"Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver","volume":"12","author":"Krause","year":"2003","journal-title":"Protein Sci"},{"issue":"15","key":"2025021210535828500_bvae214-B28","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cbic.201000400","article-title":"Structural and functional analysis of human liver-expressed antimicrobial peptide 2","volume":"11","author":"Henriques","year":"2010","journal-title":"Chembiochem"},{"issue":"2","key":"2025021210535828500_bvae214-B29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cellimm.2009.11.010","article-title":"Expression and functional analyses of liver expressed antimicrobial peptide-2 (LEAP-2) variant forms in human tissues","volume":"261","author":"Howard","year":"2010","journal-title":"Cell Immunol"},{"key":"2025021210535828500_bvae214-B30","doi-asserted-by":"crossref","first-page":"171227","DOI":"10.1016\/j.peptides.2024.171227","article-title":"Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans","volume":"177","author":"Englund","year":"2024","journal-title":"Peptides"},{"issue":"2","key":"2025021210535828500_bvae214-B31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2017.10.016","article-title":"LEAP2 is an endogenous antagonist of the ghrelin receptor","volume":"27","author":"Ge","year":"2018","journal-title":"Cell Metab"},{"issue":"2","key":"2025021210535828500_bvae214-B32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/acs.jmedchem.8b01644","article-title":"N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor","volume":"62","author":"M'Kadmi","year":"2019","journal-title":"J Med Chem"},{"issue":"7","key":"2025021210535828500_bvae214-B33","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/febs.14763","article-title":"Identifying the binding mechanism of LEAP2 to receptor GHSR1a","volume":"286","author":"Wang","year":"2019","journal-title":"FEBS J"},{"issue":"2","key":"2025021210535828500_bvae214-B34","doi-asserted-by":"crossref","first-page":"e966","DOI":"10.1210\/clinem\/dgaa803","article-title":"Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment","volume":"106","author":"Hagemann","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025021210535828500_bvae214-B35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-022-04302-5","article-title":"GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner","volume":"79","author":"Fernandez","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"2025021210535828500_bvae214-B36","doi-asserted-by":"crossref","first-page":"100582","DOI":"10.1016\/j.xcrm.2022.100582","article-title":"LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men","volume":"3","author":"Hagemann","year":"2022","journal-title":"Cell Rep Med"},{"key":"2025021210535828500_bvae214-B37","doi-asserted-by":"crossref","first-page":"110573","DOI":"10.1016\/j.mce.2019.110573","article-title":"Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region","volume":"498","author":"Barrile","year":"2019","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2025021210535828500_bvae214-B38","doi-asserted-by":"crossref","first-page":"e12785","DOI":"10.1111\/jne.12785","article-title":"Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model","volume":"31","author":"Cornejo","year":"2019","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2025021210535828500_bvae214-B39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JOE-19-0102","article-title":"Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents","volume":"244","author":"Islam","year":"2020","journal-title":"J Endocrinol"},{"key":"2025021210535828500_bvae214-B40","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.molmet.2024.101950","article-title":"A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice","volume":"84","author":"Shankar","year":"2024","journal-title":"Mol Metab"},{"key":"2025021210535828500_bvae214-B41","doi-asserted-by":"crossref","first-page":"101327","DOI":"10.1016\/j.molmet.2021.101327","article-title":"LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue","volume":"53","author":"Shankar","year":"2021","journal-title":"Mol Metab"},{"issue":"7","key":"2025021210535828500_bvae214-B42","doi-asserted-by":"crossref","first-page":"bvad061","DOI":"10.1210\/jendso\/bvad061","article-title":"Post-prandial increases in liver-gut hormone LEAP2 correlate with attenuated eating behaviour in adults without obesity","volume":"7","author":"Bhargava","year":"2023","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025021210535828500_bvae214-B43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00394-023-03304-8","article-title":"Pre-prandial plasma liver-expressed antimicrobial peptide 2 (LEAP2) concentration in humans is inversely associated with hunger sensation in a ghrelin independent manner","volume":"63","author":"Andreoli","year":"2024","journal-title":"Eur J Nutr"},{"issue":"6","key":"2025021210535828500_bvae214-B44","doi-asserted-by":"crossref","first-page":"bqac038","DOI":"10.1210\/endocr\/bqac038","article-title":"Beta-hydroxybutyrate suppresses hepatic production of the ghrelin receptor antagonist, LEAP2","volume":"163","author":"Holm","year":"2022","journal-title":"Endocrinology"},{"issue":"6","key":"2025021210535828500_bvae214-B45","doi-asserted-by":"crossref","first-page":"e22923","DOI":"10.1096\/fj.202201828R","article-title":"The dietary regulation of LEAP2 depends on meal composition in mice","volume":"37","author":"Gradel","year":"2023","journal-title":"FASEB J"},{"issue":"8","key":"2025021210535828500_bvae214-B46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/a-1210-2357","article-title":"Liver expressed antimicrobial peptide 2 is associated with steatosis in mice and humans","volume":"129","author":"Ma","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"2025021210535828500_bvae214-B47","first-page":"e220012","article-title":"Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids","volume":"27","author":"Li","year":"2022","journal-title":"Endocr Connect"},{"issue":"5","key":"2025021210535828500_bvae214-B48","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/dom.14968","article-title":"LEAP2 associated with improved pancreatic insulin secretion in adults with overweight and obesity","volume":"25","author":"Stark","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2025021210535828500_bvae214-B49","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/dom.15044","article-title":"Ketone monoester increases circulating levels of LEAP2 and decreases appetite in healthy men","volume":"25","author":"Holm","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2025021210535828500_bvae214-B50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajcnut.2023.10.007","article-title":"Nutrient sensing: LEAP2 concentration in response to fasting, glucose, lactate, and beta-hydroxybutyrate in healthy young males","volume":"118","author":"Pedersen","year":"2023","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2025021210535828500_bvae214-B51","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/nu15030655","article-title":"Plasma LEAP-2 following a low-calorie diet with or without interval exercise in women with obesity","volume":"15","author":"Ragland","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"2025021210535828500_bvae214-B52","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/SLA.0000000000000794","article-title":"The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial","volume":"260","author":"Koehestanie","year":"2014","journal-title":"Ann Surg"},{"issue":"3","key":"2025021210535828500_bvae214-B53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11695-015-1889-y","article-title":"Impact of duodenal-jejunal exclusion on satiety hormones","volume":"26","author":"de Jonge","year":"2015","journal-title":"Obes Surg"},{"issue":"7","key":"2025021210535828500_bvae214-B54","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s00464-016-5299-6","article-title":"Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study","volume":"31","author":"Betzel","year":"2017","journal-title":"Surg Endosc"},{"issue":"11","key":"2025021210535828500_bvae214-B55","doi-asserted-by":"crossref","first-page":"e018598","DOI":"10.1136\/bmjopen-2017-018598","article-title":"A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus","volume":"7","author":"Glaysher","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"2025021210535828500_bvae214-B56","doi-asserted-by":"publisher","DOI":"10.3310\/eme07060","article-title":"A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT","volume":"7","author":"Ruban","year":"2020","journal-title":"Efficacy Mech Eval"},{"issue":"4","key":"2025021210535828500_bvae214-B57","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.clnu.2020.10.026","article-title":"The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids","volume":"40","author":"Glaysher","year":"2021","journal-title":"Clin Nutr"},{"issue":"10","key":"2025021210535828500_bvae214-B58","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3390\/nu14102141","article-title":"Does bypass of the proximal small intestine impact food intake, preference, and taste function in humans? An experimental medicine study using the duodenal-jejunal bypass liner","volume":"14","author":"Aldhwayan","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"2025021210535828500_bvae214-B59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000004980","article-title":"Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity: a multicenter randomized controlled trial","volume":"275","author":"Ruban","year":"2022","journal-title":"Ann Surg"},{"issue":"11","key":"2025021210535828500_bvae214-B60","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.cgh.2013.07.029","article-title":"Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease","volume":"11","author":"de Jonge","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2025021210535828500_bvae214-B61","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s11695-022-06150-5","article-title":"Endoscopic bariatric treatment with duodenal-jejunal bypass liner improves non-invasive markers of non-alcoholic steatohepatitis","volume":"32","author":"Karlas","year":"2022","journal-title":"Obes Surg"},{"issue":"8","key":"2025021210535828500_bvae214-B62","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/M16-2937","article-title":"Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American diabetes association standards of medical care in diabetes","volume":"166","author":"Chamberlain","year":"2017","journal-title":"Ann Intern Med"},{"key":"2025021210535828500_bvae214-B63","doi-asserted-by":"crossref","unstructured":"Emini M, Bhargava R, Aldhwayan M, et al \u00a0Satiety hormone LEAP2 after low-calorie diet with\/without Endobarrier insertion in obesity and type 2 diabetes mellitus (Supplementary Material). 2024; Available from: 10.5281\/zenodo.13916834.","DOI":"10.1210\/jendso\/bvae214"},{"issue":"11","key":"2025021210535828500_bvae214-B64","doi-asserted-by":"crossref","first-page":"107996","DOI":"10.1016\/j.isci.2023.107996","article-title":"The role of dysregulated ghrelin\/LEAP-2 balance in anorexia nervosa","volume":"26","author":"Tezenas du Montcel","year":"2023","journal-title":"iScience"},{"issue":"7","key":"2025021210535828500_bvae214-B65","first-page":"564","article-title":"Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated NAFLD","volume":"188","author":"Ezquerro","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025021210535828500_bvae214-B66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000530733","article-title":"Liver-Expressed antimicrobial peptide 2 is a hepatokine that predicts weight loss and complete remission of type 2 diabetes Mellitus after vertical sleeve gastrectomy in Japanese individuals","volume":"16","author":"Nabekura","year":"2023","journal-title":"Obes Facts"},{"issue":"3","key":"2025021210535828500_bvae214-B67","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00023.2023","article-title":"LEAP2 is associated with cardiometabolic markers, but is unchanged by antidiabetic treatment in people with prediabetes","volume":"325","author":"Byberg","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2025021210535828500_bvae214-B68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/oby.22051","article-title":"A ketone ester drink lowers human ghrelin and appetite","volume":"26","author":"Stubbs","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"2025021210535828500_bvae214-B69","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/dom.14402","article-title":"Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men","volume":"23","author":"Vestergaard","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2025021210535828500_bvae214-B70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ejcn.2013.90","article-title":"Ketosis and appetite-mediating nutrients and hormones after weight loss","volume":"67","author":"Sumithran","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"11","key":"2025021210535828500_bvae214-B71","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/oby.22023","article-title":"Caloric restriction-induced decreases in dopamine receptor availability are associated with leptin concentration","volume":"25","author":"Dunn","year":"2017","journal-title":"Obesity"},{"issue":"7","key":"2025021210535828500_bvae214-B72","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/dom.13287","article-title":"Roux-en-Y gastric bypass compared with equivalent diet restriction: mechanistic insights into diabetes remission","volume":"20","author":"Pop","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2025021210535828500_bvae214-B73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MED.0000000000000379","article-title":"Potential mechanisms underlying the effect of bariatric surgery on eating behaviour","volume":"25","author":"Zakeri","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"2025021210535828500_bvae214-B74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/endrev\/bnab022","article-title":"Mechanisms of weight loss after obesity surgery","volume":"43","author":"Akalestou","year":"2022","journal-title":"Endocr Rev"},{"issue":"2","key":"2025021210535828500_bvae214-B75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4166\/kjg.2019.73.2.84","article-title":"Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin","volume":"53","author":"Kim","year":"2009","journal-title":"Korean J Gastroenterol"},{"issue":"6","key":"2025021210535828500_bvae214-B76","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1210\/jc.2007-2057","article-title":"Leptin and ghrelin in relation to Helicobacter pylori status in adult males","volume":"93","author":"Roper","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025021210535828500_bvae214-B77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.gie.2016.07.027","article-title":"Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner","volume":"85","author":"Betzel","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2025021210535828500_bvae214-B78","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11695-016-2311-0","article-title":"Endobarrier in grade I obese patients with long-standing type 2 diabetes: role of gastrointestinal hormones in glucose metabolism","volume":"27","author":"Vilarrasa","year":"2017","journal-title":"Obes Surg"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvae214\/60951948\/bvae214.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/1\/bvae214\/61228815\/bvae214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/1\/bvae214\/61228815\/bvae214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:55:34Z","timestamp":1739357734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae214\/7916583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,11,26]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae214","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,26]]},"article-number":"bvae214"}}